
YOUR IVA SURVIVED MLR.
IT DIDN’T SURVIVE THE 2min BETWEEN PATIENTS.





“I’m busy. Send it.”
The rep sends a PDF attachment. It doesn’t get opened.
Fix the format. Fix the HCP engagement.

It's not five problems.
It's one format problem.
Content that takes too long to create. Too long to approve. Too hard to reuse. Too painful to localize. Too easy to ignore.
Different teams. Different symptoms. Same root cause.
The format wasn't built for how healthcare professionals consume information today.
Most content platforms manage content.
Qoolo changes the format.
Medical micro-content wasn't created because life sciences companies wanted another format. It emerged because the old ones stopped working.
HCPs still want the science. They just don't have time for content built for a different era.
Qoolo was built for moments. The question during a scientific exchange. The 2 minutes before a rep call. The follow-up after a congress. The phone already in someone's hand.
One micro-content infrastructure.
Three products.
Built on Qoolo's patent-pending micro-content technology.
The engine behind medical micro-content. Create, approve, localize, and scale compliant mobile-first content without rebuilding workflows, adding complexity, or waiting on developers.
The same infrastructure that powers medical micro-content, built for patients. A mobile-first ePRO platform designed around how patients actually respond: on their phones, in moments, between everything else.
The micro-content engine with a relationship layer. Track contacts and their organizations, understand engagement, and connect content performance to real interactions without the cost and complexity of traditional enterprise CRM systems.
Every pharma team has
a content problem.
You just call it something different.
Pick your team.

Rep Training
Your reps don't need another training module. They need the answer 2 minutes before they walk in.

Rep & HCP Engagement
The doctor gave your rep 4 minutes. Your content was built for 20.
Conferences & Other Events
The conference didn't fail. The format did. The booth was busy. The symposium was full. The science was solid. The QR code opened a PDF. The audience photographed the slides. Everyone did their job. Except the format.


Want to know if the training or scientific narrative landed?
Micro-surveys & quizzes
The question wasn't the problem. The format was. Two questions. On a phone. Right after the interaction. Because insights follow the same rules as content. If it doesn't fit the moment, it doesn't happen.
WHAT PEOPLE
SAY ABOUT QOOLO

Your startup is ready.
Your content isn't.
You spent years getting the science right. Now you need to get in front of investors, present at conferences, and equip your first reps.
The truth is, you don't have the time or budget to build like Big Pharma. No content team. No agency on retainer. No months to wait. Qoolo gives lean teams the content infrastructure of a much larger organization.
Move like a startup. Show up like Big Pharma.
Security & compliance
Built for regulated industries. Built for life sciences.
Security should be invisible, but strong. Integrations should be optional, but available when needed. The content should be the interesting part.
AWS hosted
GDPR
HIPAA
AES
TLS
What the best teams already know.
Case studies, white papers, and more.

About Qoolo
We've sat in hundreds of MLR meetings. Managed impossible timelines. Rebuilt the same asset for different markets. We didn't just read about these problems. We lived them.
What's happening at Qoolo?
Our latest news. Funding. Partnerships. Product updates. The stuff worth knowing.

In The News
Qoolo Named an Original Innovator of 2026 by PM360
PM360 selected Qoolo for its Original Innovators 2026 issue, in the Innovative Marketing Technology or Services category, recognizing medical micro-content infrastructure as one of the year’s most game-changing innovations in healthcare.

In The News
Qoolo Unveils 'Micro-Content' Platform for Life Sciences Brands
Solli, a media platform for the global pharma industry, covered Qoolo's launch and our take on medical micro-content - scientific content built for the short mobile moments healthcare professionals actually have.

Press Release
Qoolo Launches the First Medical Micro-Content Infrastructure for Life Sciences
Qoolo Inc. today announced the public launch of the first medical micro-content infrastructure for life sciences, enabling life sciences companies to create, review, localize, publish, and measure compliant medical micro-content for both Commercial and Medical Affairs teams.

Event
Qoolo Offers a Preview of Its Platform at NS Tech Connect 2026
Qoolo recently presented at NS Tech Connect 2026, an event organized by the Science and Technology Park Novi Sad (NTP) that brought together startups and established companies from across the local innovation ecosystem.

Event
Qoolo Explores the Future of Life Sciences Innovation at AWS Life Sciences Symposium 2025
Qoolo recently attended the AWS Life Sciences Symposium 2025, an event bringing together life sciences organizations, technology leaders, and innovators to explore how cloud technologies, data, and artificial intelligence are shaping the future of healthcare and pharmaceutical innovation.
READY TO SEE QOOLO IN ACTION?
Schedule a demo today and see what happens when the format finally works.
The answers you're looking for:
Qoolo is medical micro-content infrastructure for life sciences. It's a mobile-first platform built to fix how life sciences companies package and serve medical content on phones, so it gets consumed by healthcare professionals in the moments they can engage, on the go. The life sciences industry has one root content problem: it takes too long to create, too long to approve, too hard to reuse, too painful to localize, and too easy to ignore. Different teams feel these problems differently, but it's the same format problem. Content was built for a world where doctors had time for a long conversation with a rep, or an hour at a desk in front of the laptop. That world is gone. The formats stayed, and Qoolo decided to challenge that. Qoolo changes the format to work for today's busy HCPs. Built on Qoolo's patent-pending micro-content technology, the platform lets life sciences teams create, approve, localize, scale, and analyze compliant mobile-first content - without rebuilding workflows, adding complexity, or waiting on developers.
Medical micro-content is high-integrity medical information packaged into small, purpose-built units that healthcare professionals can access anytime, anywhere on mobile. It's more than just shortening content. Done right, it preserves scientific accuracy, context, and compliance while making complex scientific information easier to understand, remember, and apply.
Qoolo is purpose-built for medical micro-content in the life sciences industry. It differs from both generic content platforms and existing life-science-specific platforms, for different reasons. Compared with generic, industry-agnostic content tools, Qoolo is built for regulated life sciences content - structured around references, safety information, auditability, MLR-ready outputs, localization, and workflows that support compliant content creation from the start, not just design and publishing. Compared with existing life-science-specific platforms, Qoolo brings a different content philosophy. Many were built around traditional eDetailing, modular assembly, or tablet-oriented experiences. Qoolo is centered on mobile-first medical micro-content, designed for how healthcare professionals actually consume information today.
Qoolo is used by teams across the life sciences industry - from Commercial to Medical Affairs, and everything in between. Commercial teams use Qoolo to build and adapt HCP-facing content, including Brand and Product Managers, Marketing, Sales, and Sales Enablement teams - for both rep training and HCP engagement. Medical teams use Qoolo to create compliant, MLR-ready scientific content, including Medical Affairs, Medical Science Liaisons (MSLs), and Medical Communications teams - supporting both MSL training and HCP engagement. Agencies supporting either function also use Qoolo to build and adapt content on their clients' behalf. Qoolo also supports global, regional, and local market teams working across markets and languages. Startups get their own layer of support. Early-stage life sciences companies often have the science figured out long before they have a content team, an agency on retainer, or months to spend building assets from scratch. Qoolo closes that gap - giving lean teams the same content infrastructure a much larger organization would have, so a five-person startup can walk into an investor meeting, a conference booth, or a rep's first call looking every bit as sharp as a company twenty times its size. In short: any life sciences team creating content that needs to be accurate, compliant, mobile-first, and reusable can benefit from Qoolo.
Qoolo is one micro-content infrastructure, built into three products. Qoolo is the flagship product - the engine behind medical micro-content, for HCP-facing teams. QClinical runs on the same infrastructure, built for patients instead of HCPs. Qoolo CRM adds a relationship layer on top, for teams who want to track contacts and engagement alongside their content. Qoolo is available now; QClinical and Qoolo CRM are both in early access.
Qoolo CRM is a lightweight CRM built on top of Qoolo's proprietary micro-content infrastructure. It combines content creation, publishing, and engagement tracking with contact and organization management, helping life sciences teams connect content performance to real HCP interactions. Unlike traditional enterprise CRM systems, Qoolo CRM is designed for small and mid-sized life sciences companies that need a simple, modern solution without unnecessary complexity. Teams can create and share content, manage relationships, and see exactly who engaged with what - all in one platform. Qoolo CRM is currently available in Early Access.








